A US judge also turned down Novo's bid to block Lilly's weight-loss ads, and Andel will offer Wegovy through an employer marketplace.
Recap by typeshit. Full story at Ad Hoc News.
A Weird Science riff frames her before and after, crediting GLP-1 medication for taking her from 233 pounds down to 133.
The Post digs into how weight loss on GLP-1 drugs may be affecting marriages, and finds the answer is not simple.
She explains that GLP-1 drugs copy a hormone the body already makes, and says they can curb appetite, slow digestion and help with blood sugar.
She landed the Daily Mail front page this week discussing Ozempic face and the steps she says she took to protect her own.
Winnipeg and Toronto meet at 1 PM ET on Halloween, airing on TSN, RDS, CTV, Crave and CFL+. A sports sponsorship, not drug news.
A 2026 records study found fewer falls on semaglutide or tirzepatide than on DPP-4 pills, while Wegovy's label shows more hip fractures in users 75 and up.
Loading…